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As the entry site into the secretory pathway, the endoplasmic reticulum (ER) is 
responsible for folding and processing secreted proteins. Both physiological and 
pathological conditions can perturb protein homeostasis in the lumen of the ER, a 
situation termed ER stress. The unfolded protein response (UPR) is an intracellular 
signaling pathway that is triggered by the accumulation of misfolded proteins in the ER, 
which is initiated by three ER transmembrane proteins (IRE1, PERK, and ATF6). 
Activation of the UPR is primarily directed towards restoring proteostasis, which is 
achieved through increasing the protein-folding capacity of the ER and reducing the 
quantity of proteins that enter the ER. If these efforts fail to rectify the condition, 
persistent ER stress initiates the signaling pathway resulting in cell death; however, how 
the UPR switches cells from adaptive programs to apoptosis is not understood well.  
It has become increasingly clear that the UPR is activated by diverse 
physiological stimuli such as glucose, lipids, oxidative stress, and differentiation signals; 
thus, UPR signaling affects broad aspects of cell fate and the metabolism of glucose and 
lipids. In fact, altered metabolism, evasion of apoptosis, and defective differentiation are 
considered hallmarks of cancer, and many studies have demonstrated that ER stress and 
UPR activation are involved in a variety of cancers. Since the role of ER stress and the 
UPR in cancer is still not completely clarified, understanding the details of the UPR-
 iv 
mediated cellular processes will give insight into the mechanism of cancer development 
and could suggest potential therapies.  
In the work presented here, I focus on how glucose metabolism is changed during 
ER stress and the mechanism underlying this metabolic shift. I have found that ATF4, 
which is downstream of PERK, is important for upregulation of genes coding for 
glycolytic enzymes and lactate dehydrogenase, which suggests a shift in glucose 
metabolism toward aerobic glycolysis during ER stress. Furthermore, I investigate 
whether aerobic glycolysis occurring in osteoblast differentiation is regulated via the 
same mechanism. Lastly, I elucidate the function of the transcription factor hairy and 
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The endoplasmic reticulum (ER) is crucial for the proper folding and processing 
of proteins that are entering the secretory pathway. The ER provides a high-fidelity 
quality control system to ensure that only properly assembled and functional proteins are 
delivered to their ultimate destinations and that unfolded and misfolded proteins are 
retained and degraded. Various biochemical, physiological, or pathological stimuli can 
cause accumulation of unfolded or misfolded proteins, a condition known as ER stress. 
To reduce ER stress and restore homeostasis, cells trigger a complex signaling pathway 
referred to as the unfolded protein response (UPR).  
Overall, the UPR promotes the protein-folding capacity of the ER by expanding 
its size and function through increased biogenesis of membrane components and 
transcription of chaperones and protein-modifying enzymes needed to fold proteins. Also, 
the UPR decreases the protein folding load on the ER by reducing general translation and 
enhancing ER-associated protein degradation. If the adaptive UPR fails to reestablish the 
ER to normality, cells commit to cell death by activating UPR-mediated cytotoxic 
pathways. However, it is largely unknown how, mechanistically, this important binary 
life or death decision is made.1-3 
Beyond its homeostatic control of protein folding, increasing evidence has 
recognized important roles of the UPR in many biological functions, such as lipid and 
glucose metabolism, differentiation,4-6 and inflammation.7-10 Thus the ability to 
understand and manipulate how the UPR participates in multiple physiological processes 
is thought to provide therapeutic insights into developmental disorders as well as many 
ER stress-related diseases, including diabetes, neurological diseases, and cancer.11-13 
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In this dissertation, I seek to determine the mechanisms underlying novel outputs 
of the UPR. Specifically, I investigate the mechanism of glucose metabolism 
reprogramming induced by ER stress in flies and determine whether cells undergoing 
differentiation, previously thought to change glucose metabolism, use the same 




One of the primary functions of the ER is to fold and process secreted proteins. In 
mammals, most of these secreted proteins enter the ER co-translationally; ribosomes 
engaged in the synthesis of these proteins are targeted to the ER by a signal sequence at 
the amino terminus of the growing polypeptide chain (Figure 1.1). As the polypeptide 
chain elongates, it passes through the translocon channel into the ER lumen where the 
signal sequence is cleaved. Then, the protein disulfide isomerase and major chaperone 
BiP, both located in the ER lumen, mediate the formation of disulfide bonds and protein 
folding, respectively. Proteins are also glycosylated on specific asparagine residues 
within the ER. Correctly folded and modified proteins are available for transport to the 
Golgi apparatus while abnormally folded proteins are retained within the ER or 
degraded.14-16  
As the most extensive membrane network, the ER contacts almost every other 
membrane-bound organelle in the cell, including mitochondria, the Golgi apparatus, 
endosomes, lysosomes, and the plasma membrane. These inter-organelle contacts allow 








Figure 1.1 Co-translational targeting of secretory proteins to the ER. Proteins possessing 
an amino-terminal signal sequence are co-translationally localized to the ER. SRP binds 
the signal sequence as it emerges from the cytosolic ribosome. This complex docks on 
the SRP receptor which is embedded in the ER membrane. Following release, SRP is 
recycled and nascent protein chains are translated through the translocon into the lumen 

















































































important role in synthesizing and transporting lipids to the ER-Golgi intermediate 
compartment so they could be distributed throughout the cell. Other functions of the ER, 
by operating in tandem with mitochondria, are to regulate apoptosis and homeostasis of 
calcium necessary for lipid synthesis, protein folding and glycosylation, apoptosis, cell 
cycle, and metabolism.17-19 Because the ER can serve as the main communication centre 
of cellular organelles coordinating various cellular processes, the ER protein folding 
environment needs to be tightly regulated.  
 
ER Stress and the Unfolded Protein Response 
ER stress is caused by an imbalance between the amount of incoming unfolded 
proteins and the capacity of the ER to process this load. Various physiological stimuli 
including differentiation, hypoxia, and nutrient deprivation and pathological conditions 
such as diabetes, neurodegenerative diseases, and cancers can cause ER stress.20-22 
Chemicals also induce ER stress by targeting different components of the ER, such as the 
ER calcium ATPase pump, protein transport machinery, and protein disulfide formation. 
Cells trigger the unfolded protein response (UPR) to reestablish ER homeostasis. 
The UPR signaling is broadly conserved across eukaryotes, and three branches of the 
UPR have been identified in metazoans: inositol-requiring protein 1 (IRE1), protein 
kinase RNA-like ER kinase (PERK), and activating transcription factor 6 (ATF6).3 The 
UPR does not only represent a stress response but is also an essential mechanism for 
normal development of multicellular organisms.14,23,24 For example, mice deficient in 
IRE1 or in both types of ATF6α and β genes show embryonic lethality.25-27 Perk 
knockout mice are viable, but exhibit severe pancreatic and skeletal defects and growth 
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retardation.24,28-30 
Under normal, nonstressed conditions, these three transmembrane proteins are 
associated with the ER resident chaperone BiP (Figure 1.2). ER stress leads to the 
dissociation of BiP from the three UPR transducers, which subsequently results in their 
activation. Upon release from BiP, ER transmembrane Ser/Thr kinase IRE1 and PERK 
homooligomerize and autophosphorylate, which in turn activates them to transmit signals 
to the cytosol.14,31,32 For example, phosphorylation of IRE1 elicits an endoribonuclease 
activity in the cytoplasmic domain, which initiates an unconventional splicing of X-box 
binding protein 1 (XBP1) mRNA. Dissociation of BiP from ATF6 allows translocation of 
ATF6 to the Golgi apparatus for processing by proteases to release the transcription 
activating form of ATF6.33-37 
The UPR basically allows cells to enhance ER functions by inducing transcription 
of various genes, such as ER chaperones to increase the protein-folding capacity of the 
ER and genes involved in lipid biosynthesis to expand the volume of the ER.30,38,39 This 
broad transcriptional program is mediated by XBP1, ATF6, and ATF4, which is a 
downstream target of PERK. To reduce the protein folding load on the ER, general 
protein synthesis is inhibited via phosphorylation of the cytosolic eukaryotic translation 
initiation factor 2α (eIF2α) at Ser51 by PERK, which halts the initiation of translation 
but selectively increases the translation of mRNA containing upstream open reading 
frames including ATF4. Regulated IRE1-dependent decay (RIDD), which degrades ER-
localized mRNAs by IRE1, may also help to reduce the folding load of nascent proteins 
entering the ER.33,40,41 Additionally, ER-associated protein degradation (ERAD), which 






Figure 1.2 The three main signaling branches of the UPR. During unstressed conditions 
(top panel), the BiP chaperone binds to the luminal domain of the ER transmembrane 
proteins, PERK, IRE1, and ATF6, maintaining them in an inactive state. When unfolded 
proteins are accumulated in the lumen of the ER (bottom panel), BiP is dissociated from 
the UPR transducers, leading to their activation. The UPR aims to restore ER 











































































unfolded protein load.  
 
UPR-Mediated Cellular Metabolism 
The first scientific question I have in Chapter 2 is how the UPR is linked to 
central carbon metabolism, particularly glycolysis, during ER stress. Considering that the 
ER is an integral contributor to cellular metabolism, such as protein synthesis and 
degradation, calcium homeostasis, gluconeogenesis, and lipid synthesis, UPR activation 
is central to regulation of both glucose and lipid metabolism.44-46 In addition, the 
influence of UPR signaling on metabolic diseases, such as type 2 diabetes, insulin 
resistance, and non-alcoholic fatty liver disease, has been extensively documented in 
recent years.2,4,47 
The role of the UPR in glucose homeostasis is relatively well established in 
insulin-secreting pancreatic β cells and hepatocytes that are responsive to insulin and 
glucagon. The importance of translational control by PERK in glucose homeostasis in β 
cells has been supported by studies using PERK-null mice and mice with a homozygous 
mutation at the eIF2α phosphorylation site (Ser51Ala). Both mice showed hyperglycemia 
associated with loss of pancreatic islets and defective gluconeogenesis, 
respectively.35,44,48,49 Such islet dysfunctions were not reported in mice lacking GCN2 
(general control nonderepressible 2). Moreover, when PERK expression was 
reintroduced in β cells of PERK-null mice, the mice became euglycemic and displayed 
normal β cell.50,51 Transcriptional networks activated by the UPR also target expression 
of genes important in glucose metabolism. Genes involved in glucose output and 
glycogen synthesis, such as glycogen synthase 1, are targets of XBP1.52-54 ATF4 also 
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augments gluconeogenesis by controlling the transcriptional activity of forkhead box 
protein O1 (FOXO1), which promotes hepatic gluconeogenesis and inhibits glucose 
utilization.1 Although the overall requirement for ATF6 in glucose homeostasis remains 
unclear, it seems to reduce liver glucose production by inhibiting expression of 
gluconeogenic genes.4 
UPR also regulates the process of de novo lipid biosynthesis, lipogenesis, to 
accommodate the need for ER expansion. The PERK-eIF2α and IRE1-XBP1 branches of 
the UPR can activate sterol regulatory element-binding protein (SREBP) 1 and 2, which 
are important transcriptional activators of fatty acid and cholesterol synthesis.7,9 Unlike 
the other UPR branches, ATF6 seems to function in fatty acid oxidation rather than in 
lipid biosynthesis.11 The regulation of lipogenesis by the UPR needs to be further 
investigated to better understand exactly how UPR-induced transcriptional programs are 
integrated into classical lipid metabolism regulation.  
It is clear that activation of the UPR modulates gluconeogenesis and lipogenesis 
during ER stress to increase the ER capacity, although how the metabolism of glucose 
and lipid is differentially regulated by the UPR in different organs still requires further 
investigation. Moreover, there are relatively few studies connecting the UPR and 
glycolysis, even though relationships between glycolysis, lipogenesis, and other 
intermediate metabolites have been studied.  
 
UPR-Mediated Differentiation 
In Chapter 3, I address the second scientific question, whether the mechanism of 
ER stress-induced metabolic shift, which we found in Chapter 2, contributes to metabolic 
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reprogramming during osteoblast differentiation. As noted above, the UPR is required for 
development in multicellular organisms. It is important especially for secretory cells 
(Table 1.1), which expand their ER during development.14 The role of the UPR in cell 
differentiation was first demonstrated by the requirement for the IRE1-XBP1 branch in 
the differentiation of B cells into antibody-secreting plasma cells.17 Induction of XBP1 is 
required for the increased ER expansion and protein synthesis necessary for high levels 
of antibody production and secretion upon antigenic stimulation. It was initially thought 
that IRE1-XBP1 was activated by excessive protein folding-load on the ER due to 
massive immunoglobulin synthesis. However, the expansion of the ER was observed in B 
cells before the onset of immunoglobulin synthesis,20 and mice engineered to abrogate 
IgM secretion showed normal XBP1 mRNA splicing.23 These results suggest that 
differentiation of plasma cells is accompanied by the XBP1-mediated ER expansion, 
which might anticipate, rather than occur as a consequence of massive antibody 
production. ATF6 is also known to be activated during plasma cell differentiation, but its 
contributions to this process are not understood.25 Unlike other branches of the UPR, 
PERK remained inactive in differentiating B cells, and mice having non-
phosphorylatable eIF2α still showed B cell maturation and plasma cell 
differentiation.24,29 Taken together, these findings imply that B cells activate UPR in 
order to accommodate sustained high levels of secretion by expanding ER rather than to 
limit the protein folding burden via translational control.  
In contrast to differentiating B cells, all three branches of the UPR are activated 
during differentiation of osteoblasts. These cells secrete a large amount of type I collagen 
and other extracellular matrix proteins that form compact bone. However, whether UPR  
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branch Outputs Ref. 
Plasma cell Antibody secretion 
XBP1 
Expansion of the ER 15, 16 
Biosynthesis and secretion of IgM 18, 19 
Transition from a  membrane-bound to 
a secreted form of Ig mRNA 21, 22 
IRE1 
Expression of Rag1/2 and terminal 
deoxynucleotidyl transferase essential 
for Ig gene rearrangement 
14, 24 
ATF6 
Its role has not been established but its 







IRE1 Proinsulin biosynthesis 28, 30 
XBP1 Insulin secretion and glucose control 31, 32 
PERK 
It has been hypothesized that it 
modulates proinsulin quality control 
and trafficking 
34, 36 








Lipid and/or cholesterol biosynthesis 40, 41 
XBP1 
Expression of α-fetoprotein and 
several acute phase response genes 
that promote hepatocyte 












Expression of Osterix, one of the 





Expression of Osteocalcin (Ocn) and 
Bone sialoprotein (Bsp), which are 
mature osteoblast markers 
4, 47 
ATF4 Type I collagen synthesis 35,48,49 








Expansion of the ER  
Expression of Mist1, the transcription 




activation is a direct consequence of increased collagen secretion or is anticipated by 
other differentiation signals is not clear. Bone morphogenetic protein 2 (BMP2) 
signaling, which is required for osteoblast differentiation, likely is involved in inducing 
the UPR.14 Since both PERK- and ATF4-null mice exhibited severe skeletal defects, the 
role of PERK-ATF4 branch in osteoblast differentiation is relatively well studied as 
compared to that of other UPR branches.33,35,37 PERK null mice showed a reduced 
number of mature osteoblasts and reduced type I collagen secretion,30 which was 
associated with altered expression of key regulators of osteoblast development, such as 
Runx2 and Osterix.33 Moreover, the trafficking and secretion of type I collagen were 
compromised by abnormal ER retention of procollagen in PERK knockout osteoblasts, 
which leads to reduced mature collagen production and mineralization. While ATF4-null 
mice did not show a significant change in Runx2 and Osterix levels, they reduced 
synthesis of type I collagen due to a decrease in amino acid import, a previously known 
function regulated by ATF4 in other cell types.35,37 These findings indicate that both 
PERK and ATF4 act as novel regulators of osteoblast differentiation and function, 
suggesting that secretory cells customize the UPR to fit their needs.   
 
Cell Death Pathway Induced by the UPR 
The last scientific question I have in Chapter 4 is how the transcription factor 
Hes1 controls ER stress-mediated cell death. If the ER stress is prolonged and/or severe, 
and the UPR fails to restore the ER function, cells undergo apoptotic cell death by 
activating pro-apoptotic pathways of the UPR (Figure 1.3). Cell death under ER stress 









Figure 1.3 UPR-mediated apoptosis. Prolonged ER stress induces apoptosis through 
various pathways. Activation of the PERK-ATF4 branch induces transcription of the pro-
apoptotic transcription factor CHOP. Active IRE1 recruits TRAF2 to activate ASK1 and 
downstream JNK, which is involved in a variety of pro-apoptotic signaling. Solid lines 


















































































activation of the proapoptotic proteins BAX and BAK by BH3 (BCL2 homology domain 
3)-only proteins is a key step in this apoptosis pathway. Oligomerization of Bax and Bak 
is followed by permeabilization of the outer mitochondrial membrane and the release of 
cytochrome c from mitochondria. Cytosolic cytochrome c leads to caspase activation and  
subsequent cell death.  
IRE1 induces apoptosis through the interaction with tumor necrosis factor 
receptor-associated factor 2 (TRAF2) and activating apoptosis signal-regulating kinase 1 
(ASK1).2 ASK1 enhances JUN N-terminal kinase (JNK) signaling which phosphorylates 
B cell lymphoma 2 (BCL2) to eliminate the anti-apoptotic effect of BCL2. Besides 
BCL2, JNK also phosphorylates and activates BH3-only proteins. Collectively, these 
changes allow oligomerization of the pro-apoptotic Bax and Bak.  
Signaling through the PERK branch of the UPR also promotes apoptosis through 
C/EBP-homologous protein (CHOP, also known as GADD153) which is an ATF4 target 
gene.44 As a leucine zipper transcription factor, CHOP has been reported to play a major 
role in promoting apoptosis by repressing the expression of antiapoptotic proteins such as 
BCL2, and inducing the expression of proapoptotic proteins, including many BH3-only 
proteins, death receptor 5 (Dr5), and GADD34.2,3 Dr5 triggers caspase 8-induced 
BAX/BAK activation, which subsequently results in cytochrome c release.5,6 Expression 
of GADD34 correlates with apoptosis induced by various signals, and its overexpression 
can initiate or enhance apoptosis.8,10 Because GADD34 is a protein phosphatase 1 (PP1)-
interacting protein, release of the translational block via dephosphorylation of eIF2α by 
GADD34 has been thought to cause cell death12,13; however, the mechanism by which 
GADD34 promotes apoptosis is still not clear.  
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Research so far has identified many components involved in the UPR-mediated 
cell death during ER stress; however, relatively little is known about how cells integrate 
the various proapoptotic signals to induce cell death. Furthermore, the mechanisms 
regulating the transition from an adaptive to apoptotic regime remain largely unknown.  
 
Concluding Remarks 
 The widespread network of the ER in cells allows signals to reach several 
contacting organelles and subsequently coordinate a widespread cellular response to a 
particular cue. In fact, it is now becoming clear that the UPR, a signaling pathway 
induced by ER stress, provides a signaling framework into which other cellular pathways 
are intimately integrated, thereby having regulatory effect on various cellular processes, 
such as apoptosis, metabolism, and differentiation, other than protein folding and 
processing.  
Although many physiological inputs that elicit UPR signaling are now known, the 
key question of how the UPR output alleviates ER stress by regulating a wide range of 
cellular functions still remain unclear. To better understand novel outputs of the UPR that 
are not directly linked to protein misfolding, I have used molecular biology techniques 
and chemical induction of ER stress.  In Chapter 2, I address the question of how glucose 
metabolism is altered and the UPR is involved in regulation of metabolic change during 
ER stress. I describe the mechanism of regulation of genes encoding for the enzymes 
involved in central carbon metabolism during ER stress in Drosophila S2 cells. Based on 
our understanding of regulation of glucose metabolism by ER stress, I determine whether 
the same mechanism is exploited by cells undergoing BMP2-induced osteoblastic 
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differentiation in Chapter 3. Finally, I describe a new molecular mechanism controlling 
overall cell fate decisions under ER stress in Chapter 4. 
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Glucose, a major source of cellular energy and new cell mass, is metabolized via 
glycolysis to pyruvate, which can enter the mitochondria and the tricarboxylic acid 
(TCA) cycle to produce reducing equivalents for oxidative phosphorylation (OXPHOS). 
The majority of ATP is produced through OXPHOS in most cells. However, under 
conditions of hypoxia, OXPHOS is limited and cells primarily rely on glycolysis to 
compensate for the decrease in ATP production, converting the excess pyruvate to 
lactate.1 This shift from OXPHOS to glycolysis is seen in a variety of cancers, regardless 
of availability of oxygen, an effect known as aerobic glycolysis or the Warburg effect.2  
This metabolic reprogramming also has been reported in differentiation of various 
kinds of cells.3-5 Lactate dehydrogenase A (LDHA), which converts pyruvate to lactate, is 
a key enzyme for aerobic glycolysis. LDHA promotes differentiation of T helper 1 cells 
by increasing acetyl-coenzyme A to increase expression of pro-inflammatory cytokine 
interferon-γ.4 Another study using a mouse bone marrow stromal cell line, ST2, provides 
an example of how aerobic glycolysis is regulated during osteoblast (bone forming cell) 
differentiation in response to WNT3A. Depletion of RICTOR, an mTORC2 component, 
abolished WNT3A-induced glucose consumption and lactate production. Moreover, 
knockdown of either RICTOR or LDHA suppressed expression of osteoblast marker 
genes by WNT3A, suggesting that metabolic reprogramming contributes to WNT-
induced osteoblast differentiation.5 However, the specific mechanism underlying this 
event and how increased glycolysis plays an important role in differentiation still remain 
to be elucidated. 
As described in Chapter 2, during ER stress, Drosophila melanogaster shift their 
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metabolism toward aerobic glycolysis by increasing transcription of glycolytic genes and 
lactate dehydrogenase (Ldh).6 In addition to protecting cells from ER stress, the unfolded 
protein response (UPR) has essential roles in the development of cells specializing in 
secretion.7 For example, the ER membrane is actively expanded in pancreatic acinar cells 
(which produces digestive enzymes), plasma cells (which secrete antibodies during an 
immune response), and osteoblasts (which secrete collagen to form bones) as they 
differentiate into highly secretory cells to promote the capacity of ER. The role of the 
UPR in plasma cells has been well-characterized: the IRE1-Xbp1 branch is required for 
expansion of the ER and antibody secretion,8 while PERK is completely dispensable in 
plasma cell differentiation.9 Unlike plasma cells, both IRE1 and PERK branches are 
necessary in osteoblast differentiation for increasing transcription of osteoblast-specific 
genes, osterix and osteocalcin, respectively.10,11 However, the mechanism underlying ER 
expansion in osteoblasts is largely unknown. Given that osteoblasts rely on all three 
branches of the UPR during differentiation,10-12 ER expansion in osteoblasts may proceed 
through a different mechanism as that in plasma cells.  
In this chapter, we hypothesized that the UPR acts as a switch for aerobic 
glycolysis during osteoblast differentiation. Furthermore, since glycolytic intermediates 
are important for lipogenesis, we speculated that increased glycolysis promotes ER 
expansion to cope with increased production of extracellular matrix (ECM) proteins as 










Figure 3.1. A model for how UPR links glucose metabolism to ER expansion. In 
response to increased demand for ECM proteins synthesis as MC3T3-E1 cells 
differentiate into osteoblasts, the UPR is activated. We hypothesized that the UPR 
induces expression of glycolytic genes that shift toward increased aerobic glycolysis. 
Increased production of glycolytic intermediates is important for the expansion of the ER 










Materials and Methods 
Cell culture and differentiation 
Pre-osteoblast mouse MC3T3-E1 cells were obtained from American Type 
Culture Collection (Manassas, VA). They were maintained in MEMα with nucleosides 
and no ascorbic acid (Invitrogen) supplemented with 10% fetal bovine serum (FBS) at 
37°C and 5% CO2. We added 100 ng/mL bone morphogenic protein 2 (BMP2), 50 
µg/mL ascorbic acid (AA), and 10 mM β-glycerophosphate (βGP) to cell media for 
indicated days to induce osteoblast differentiation.  
 
mRNA isolation and analysis 
Total RNA was isolated using Quick-RNA MiniPrep kits (Zymo Research, Irvine, 
CA). We then synthesized cDNA using 1 µg – 2 µg of RNA as template, a T18 primer, 
and MMLV reverse transcriptase (NEB). Relative mRNA levels were measured by 
quantitative PCR (qPCR) using the Masterplex ep realplex (Eppendorf) with SYBR green 
fluorescent dye. Target mRNA levels were normalized to those of ribosomal protein 19 
(Rpl19) mRNA and to day 0 cells. All primer sequences are listed in Table 3.1.  
 
RNA interference 
For the Atf4 knockdown experiment, we followed RNAiMAX (Invitrogen) 
protocols to transfect cells with Atf4 siRNAs (Sigma). Negative siRNAs (Qiagen) were 
added to cells as a control. We incubated cells for 48 h before treating with and without 





Table 3.1. Primers used for qPCR and splicing assay 
 
Name Sequences (5´- 3´) 
Rpl19 Forward: CTGATCAAGGATGGGCTGAT Reverse: GCCGCTATGTACAGACACGA 
OCN Forward: AGCAGGAGGGCAATAAGGTAG Reverse: TGCCAGAGTTTGGCTTTAGG 
Osx Forward: GACCACTTGAGCAAACATCAGC Reverse: TATCTCATCCCCAGGAAACG 
Runx2 Forward: CTTCTCCAACCCACGAATGC Reverse: TATGGAGTGCTGCTGGTCTG 
Wnt3a Forward: CTGGCAGCTGTGAAGTGAAG Reverse: TGGGTGAGGCCTCGTAGTAG 
Lrp5 Forward: AATCAACAAGCCACCCTCTG Reverse: GGCTCCACCAACATACTCGT 
Pfk(m) Forward: TGTCACCTCTCTGTCCTGTG Reverse: GGCTTCCCGTTCTTGTCGAT 
Ldh(a) Forward: AACATGGCGACTCCAGTGTG Reverse:  ACTGTCCACCACCTGCTTGT 
Xbp1 Forward: AGAAGAGAACCACAAACTCCAG Reverse: GGGTCCAACTTGTCCAGAATGC 










Xbp1 splicing assay 
We did PCR with primers that surround the Xbp1 splice site and ran the products 
on a 2% agarose gel (100 V for 2 h). As a positive control, we treated MC3T3-E1 cells 
with 1 mM DTT for 4 h to induce ER stress. 
 
Lactate measurement 
A day before measuring lactate levels, the media from the cell culture was 
changed with serum free DMEM (SFM), because lactate dehydrogenase in FBS and 
pyruvate in our standard media interfered with the lactate assay. After changing the 
media, we treated cells with and without BMP2, AA, and βGP. We collected the 
conditioned media from the cells 12 and 24 h after replacing the media. The 
concentration of lactate produced by the cells was determined using the Lactate 
Colorimetric Assay Kit II (BioVision) according to the manufacturer’s protocol. We 
measured the absorbance at 450 nm on a Synergy MX microplate reader (Biotek) and 
divided the concentration of lactate by the number of cells.  
 
Western blotting  
We lysed MC3T3-E1 cells in RIPA buffer containing protease and phosphatase 
inhibitors. Protein concentration was measured with the BCA method (Pierce). Proteins 
(10 – 20 µg for phospho-eIF2α and 40 µg for ATF4) were resolved on 4 - 12% gel 
(Invitrogen) and transferred onto a nitrocellulose membrane (Fischer). We blocked the 
membrane for 1 h at room temperature in 1% BSA in TBST containing 0.05% Tween 20, 
followed by an overnight incubation at 4 °C with anti-phospho-eIF2α (Ser51, ab32157, 
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Abcam, 1:500 or 1:1000) or anti-ATF4 antibody (C-20, Santa Cruz, 1:250). Membranes 
were then washed three times with TBST and further incubated with the secondary 
antibody, IRDye800CW conjugate goat anti-rabbit IgG (Licor, 1:10,000) in 1% BSA 
(TBST/ 0.05% Tween 20) for 1 h at room temperature. After being washed three times 
with TBST and a final wash with TBS, the blots were developed using Licor imaging 
software.  
 
ER staining for analysis of ER expansion 
After culturing cells in the absence and presence of BMP2, AA, and βGP, we 
added fresh media containing ER-Tracker blue-white DPX dye (Invitrogen, 1 µM) for 30 
min at 37 °C to cells. After staining, we washed cells three times with PBS and analyzed 
cells stained with ER-Tracker on BD FACSAria cell sorter at the University of Utah 
Flow Cytometry facility.  
 
Results 
Pre-osteoblast mouse MC3T3-E1 cells increase lactate production 
during BMP2-induced differentiation 
The classical method for osteoblast differentiation in vitro is based on the 
treatment of confluent pre-osteoblasts with BMP2, the potent regulator of osteoblast 
differentiation, in combination with AA and βGP.13 AA is an essential cofactor for the 
hydroxylation of proline and lysine residues in collagens, which are the most abundant 
ECM proteins, and βGP serves as a source for the phosphate required for calcification. 
To determine whether we could induce osteoblast differentiation in our cell culture 
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system, we used pre-osteoblast mouse MC3T3-E1 cells, and three differentiation-
inducing factors, BMP2, AA, and βGP. MC3T3-E1 cells treated with all three 
differentiation-inducing factors  showed elevated levels of differentiation marker genes 
over time as compared to untreated or AA/βGP-treated cells (Figure 3.2), indicating 
BMP2 promotes differentiation of MC3T3-E1 cells. Next, we examined whether 
MC3T3-E1 cells shift their glucose metabolism under BMP2-induced differentiation by 
measuring lactate produced by the cells. We incubated cells with and without 
BMP2/AA/βGP for 1, 3, and 6 days. We then replaced the media with serum free media 
(either supplemented with and without BMP2/AA/βGP) and measured the lactate that 
accumulated over the following 24 h. There was no change in lactate production between 
untreated and BMP2/AA/βGP-treated cells at day 2 (Figure 3.3A). However, 
BMP2/AA/βGP-treated cells produced more lactate as compared to untreated cells at day 
4 and day 7, suggesting differentiating cells rely more heavily on glycolysis.  
WNT signaling is known to stimulate aerobic glycolysis in ST2 cells, a mouse 
bone marrow stromal cell line known to undergo osteoblast differentiation in response to 
WNT3A. We therefore tested whether the WNT signaling pathway is involved in the 
metabolic shift during BMP2-induced differentiation. We measured mRNA levels of 
Wnt3a and Lrp5 from MC3T3-E1 cells treated with either nothing or BMP2/AA/βGP. 
These mRNAs were not up-regulated in differentiating cells (Figure 3.3B). Thus, BMP2 
promotes aerobic glycolysis in MC3T3-E1 cells, but does so independently of the WNT 
signaling pathway.  
We next examined the molecular basis for the increased glycolysis. Since a 







Figure 3.2. Osteoblast differentiation marker genes are up-regulated in MC3T3-E1 cells 
upon BMP2 treatment. (A) We cultured MC3T3-E1 cells in the absence or presence of 
BMP2/AA/βGP for 3 to 4 days. (B) To monitor expression of differentiation marker 
genes over time, we cultured cells with nothing, AA and βGP only, or BMP2, AA, and 
βGP for indicated days, then measured relative RNA levels by qPCR. mRNA levels were 
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Figure 3.3. BMP2 promotes lactate production in osteoblasts. We incubated MC3T3-E1 
cells with and without BMP2/AA/βGP for 2, 4, or 7 days. (A) We measured lactate levels 
in the culture media following incubation in SFM for indicated times. (B) We measured 
relative RNA levels of (B) Wnt3a and Lrp5, (C) Glut1, Pfk, and Ldh from MC3T3-E1 
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lactate production in response to ER stress, we decided to test if increased lactate 
production during BMP2-induced differentiation resulted from the increased expression 
of glycolytic genes or Ldh. However, glucose transporter 1 (Glut1), a main glucose 
transporter, phosphofructokinase (Pfk), a rate limiting enzyme in glycolysis, and Ldh 
were not changed upon BMP2/AA/βGP treatment (Figure 3.3C), suggesting that the 
metabolic shift during osteoblast differentiation induced by BMP2 does not involve 
transcriptional regulation of genes encoding these glycolytic enzymes.  
 
The UPR is not induced during BMP2-dependent osteoblast  
differentiation 
 To assess the potential involvement of the UPR in the metabolic shift during 
osteoblast differentiation, we first asked whether the UPR is activated in differentiating 
cells upon BMP2/AA/βGP treatment. Spliced Xbp1 was not observed at all in any of the 
experimental conditions, except the 1 mM DTT-treated control cells (Figure 3.4A). We 
also measured phospho-eIF2α and ATF4 protein to check PERK activity, and both levels 
were increased over time regardless of BMP2/AA/βGP treatment (Figure 3.4, B and C). 
Therefore, we had no indication that the UPR is activated during BMP2-induced 
osteoblast differentiation. 
 
Expansion of the ER membrane occurs in BMP2-induced  
differentiation of osteoblasts 
It is known that glycolytic intermediates are important for lipogenesis14; hence, 









Figure 3.4. Major branches of the UPR are not activated during BMP2-induced 
osteoblast differentiation. We cultured MC3T3-E1 cells with indicated differentiation-
inducing factors for indicated days. (A) Shown are agarose gels with the spliced (s) and 
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blocks necessary for ER membrane expansion of osteoblasts. To test this, we first 
checked whether ER is expanded during BMP2-induced osteoblast differentiation by 
selectively staining the ER with ER-Tracker. We carried out flow cytometric analysis of 
ER-Tracker staining, and our preliminary result showed a 16% increase in fluorescence 
in BMP2/AA/βGP-treated MC3T3-E1 cells as compared to untreated cells (Figure 3.5). 
Since this experiment was done at a fairly early time during differentiation, we predict 




Our goal in this project was to determine whether the UPR regulates glycolysis 
during BMP2-induced osteoblast differentiation and examine whether this metabolic shift 
is important for ER membrane expansion.  We demonstrated that aerobic glycolysis, as 
measured by lactate production, occurs during BMP2-induced osteoblast differentiation 
(Figure 3.3A). Unexpectedly, we found no indication that the UPR is activated by BMP2 
treatment (Figure 3.4, A, B, and C). This finding was surprising because several studies 
have shown activation of the UPR during BMP2-induced osteoblast differentiation.10,11 
The discrepancy could be due to different controls for comparing expression of target 
genes and proteins; for example, phospho-eIF2α level seems to increase in 
BMP2/AA/βGP-treated cells when compared with day 0; however, day 4 and 7 cells 
treated with BMP2/AA/βGP do not have more phospho-eIF2α as compared with the 
corresponding cells without BMP2/AA/βGP treatment (Figure 3.4B). Increased levels of 








Figure 3.5. BMP2 treatment induces ER expansion of osteoblast. MC3T3-E1 cells were 
treated with and without BMP2/AA/βGP for 3 days, stained with the ER-specific dye 
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cells grown to confluence typically exit cell cycle, which is accompanied by active 
PERK. Previous studies reporting PERK activation during osteoblast differentiation did 
not consider this issue. Lack of spliced XBP1 in our study is more difficult to explain, but 
this could be due to the differences in our experimental design: for example, the types of 
cells and method of differentiation. Taken together, our data suggest that the metabolic 
shift observed in response to BMP2 is UPR-independent, and we decided to not pursue 
this project further at this time. 
It has previously been reported that there is functional cross-talk between WNT 
and BMP2 signaling in mesenchymal differentiation, so BMP2 in combination with 
WNT3A has an inductive effect on osteoblast differentiation.15 A recent study by Esen et 
al. showed that WNT-LRP5 signaling is involved in metabolic reprograming during 
osteoblast differentiation in response to WNT3A.5 However, we did not see increased 
expression of Wnt3a and Lrp5 upon BMP2 treatment (Figure 3.3B). Although this result 
indicates that WNTL-LRP5 does not regulate glucose metabolism during BMP2-induced 
osteoblast differentiation, it would be interesting to examine whether and how the UPR is 
involved in regulation of aerobic glycolysis in WNT3A-induced osteoblast 
differentiation.  
The benefits of increased glycolysis to cells during differentiation remain to be 
investigated. Our results in the present study showing that metabolic shift toward 
glycolysis and ER expansion occur during BMP2-induced osteoblast differentiation 
raises the possibility that glycolytic intermediates can be bled off for anabolic synthesis 
of phosphatidylcholine (PtdCho), a major source of ER membrane, for ER expansion. 
Indeed, phosphatidic acid, which is required for PtdCho synthesis, is derived from the 
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glycolytic intermediate.16 This possibility is further supported by studies showing that 
increased synthesis of PtdCho triggers expansion of the ER in cells undergoing ER stress 
to promote its capacity for protein folding.17,18 
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HES1 PROTECTS CELLS FROM ER STRESS-INDUCED CELL  

































Disruption in ER function, termed ER stress, occurs in a variety of diseases such 
as neurodegenerative diseases, diabetes, and cancer. In response to ER stress, cells induce 
the unfolded protein response (UPR), whose activation triggers a broad transcriptional 
program. Those genes regulated by UPR generally encode ER-resident protein folding 
machinery, ER-associated protein degradation components, and other proteins of 
importance to ER function. We found that hairy and enhancer of split 1 (Hes1) mRNA is 
strongly stabilized during ER stress in a variety of cell types. The transcriptional 
repressor Hes1 is involved in the regulation of cell fate decisions as a primary target of 
the Notch signaling pathway; however, it does not have any obvious link to ER function. 
We found that Perk’s ability to attenuate translation was important for Hes1 induction 
and depletion of Hes1 significantly reduced cell survival in response to ER stress. ER 
stress-induced cell death in Hes1 knockdown cells was due to increased expression of 
Gadd34, a protein known to regulate apoptosis during ER stress. Thus, our results 
identify Hes1 as a negative regulator of apoptosis that determines overall cell fate in 
response to ER stress.  
 
Introduction 
As a central organelle in the secretory pathway, the endoplasmic reticulum (ER) 
is responsible for protein folding and posttranslational modifications. Alterations in ER 
functions can arise from various stimuli such as increased secretory protein synthesis and 
chemical treatment, which leads to the accumulation of unfolded or misfolded proteins in 
the ER lumen. These perturbations are referred to as ER stress. Because misfolded 
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proteins are potentially toxic to the cell, the ER responds to stress through the unfolded 
protein response (UPR) pathway.1 This collection of signaling pathways relieves the 
protein-folding load on the ER by global translational attenuation and mRNA decay,2,3 
while it simultaneously increases the ability of the ER to fold proteins by up-regulating 
genes encoding ER-specific chaperones and proteases.1  
The UPR is initiated by the action of three signaling proteins: PKR-like ER kinase 
(PERK), inositol-requiring 1 (IRE1), and activating transcription factor 6 (ATF6). 
Translational regulation is mainly mediated by PERK, which phosphorylates eukaryotic 
translation initiation factor 2 (eIF2α).2 This inhibits general translation but promotes 
synthesis of protein such as ATF4, whose mRNAs contain upstream open reading 
frames.4 ATF4 subsequently activates transcription of ER chaperones and genes involved 
in amino acid metabolism and antioxidant pathways, which are all required for ER 
quality control.5 A second transducer of the UPR is IRE1, whose endoribonuclease is 
activated by ER stress. Active IRE1 cleaves mRNAs localized to the ER, leading to their 
degradation through regulated Ire1-dependent decay (RIDD).6 It also mediates 
unconventional splicing of the mRNA encoding the transcription factor X-box-binding 
protein 1 (XBP1),7 thereby increasing expression of many genes encoding ER chaperones 
and other proteins that function in the secretory pathway.8 ATF6 is activated by 
proteolysis during ER stress and, along with ATF4 and XBP1, up-regulates genes 
necessary to reestablish protein homeostasis.9  
In addition to its cytoprotective roles, the UPR induces apoptotic cell death if the 
ER stress is not mitigated.10 Ire1 recruits TNF receptor-associated factor 2 (TRAF2), 
which interacts with apoptotic-signaling kinase-1 (ASK1),11 triggering kinase cascades 
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that promote apoptosis.12,13 The PERK-ATF4 branch up-regulates a pro-apoptotic 
transcription factor, C/EBP homologous protein (Chop), causing changes in gene 
expression that favor apoptosis.14,15 For example, Chop-mediated activation of GADD34 
enhances dephosphorylation of eIF2α, reversing translational attenuation, which further 
increases the protein-folding burden on the ER.16 Although many studies have uncovered 
molecules involved in the ER stress-related apoptosis pathway, it is still unclear how the 
numerous signals from the stressed ER are integrated and cells decide to activate 
apoptosis.  
In the current study, we report a novel role of hairy and enhancer of split 1 (Hes1) 
in cell fate decisions during ER stress. Hes1 is a member of the basic helix-loop-helix 
transcriptional repressors.17 As a primary target of the Notch signaling pathway, Hes1 is 
known to regulate cell quiescence and proliferation in the development of multiple organs 
and cell types.18 Also, nonconventional function of Hes1 has recently been highlighted by 
the finding that Hes1 attenuates inflammatory response via repression of chemokine 
transcription.19 Here we show that Hes1 is strongly up-regulated by the UPR and affects 
the survival of cells exposed to chemical inducers of ER stress. 
 
Materials and Methods 
Cell culture and treatments  
We cultured pre-osteoblast mouse MC3T3-E1 (American Type Culture 
Collection) in MEMα with nucleosides and no ascorbic acid (Invitrogen), Hek293 and 
3T3 cells in DMEM (Dulbecco’s modified Eagle’s media) at 37°C and 5% CO2, and 
Drosophila S2 cells (Invitrogen) in Schneider’s media at room temperature. All media 
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were supplemented with 10% heat inactivated fetal bovine serum (FBS). To induce ER 
stress, we added 2 mM dithiothreitol (DTT, Sigma-Aldrich) or 2 µM thapsigargin (Tg, 
Sigma-Aldrich) to cell media. For inhibition of transcription or translation, we treated 
cells with 2 µg/mL Actinomycin D or 35 µM cycloheximide (CHX), respectively. To 
inhibit the integrated stress response, we added 500 nM ISRIB (kind gift from the Peter 
Walter lab, University of California at San Francisco) to cells for ~ 5 min before adding 
ER stressors. To induce HRI-mediated eIF2α phosphorylation, we treated cells with 100 
µM arsenite.  
 
RNAi 
To deplete S2 cells of individual UPR transducers, we used PCR to amplify 
regions of cDNAs encoding Ire1, Xbp1, Atf6, Perk, Atf4, Nrf2, NFkB, using S2 cell 
cDNA as a template and primers containing T7 RNA polymerase sites on the 5’ ends. As 
a control, we amplified a region of the GFP coding sequence. We then used these PCR 
products to generate dsRNA by in vitro transcription (Megascript T7 kit, Ambion). We 
incubated S2 cells with dsRNA in serum free media for 45 min, replaced the serum, and 
allowed the cells to recover for 4-5 days. We then repeated the dsRNA treatment and 
induced ER stress 1 day following the second dsRNA treatment. For RNAi in 
mammalian cells, we followed Invitrogen RNAimax guidelines for transfection of 
siRNAs. We combined multiple siRNAs (Qiagen) targeting each gene (Table 4.1). 
Negative siRNA-transfected cells were included as a control for all experiments. We 
subjected cells to inhibitors and/or ER stressors 48-72 h after transfection, when cells 




Table 4.1. List of siRNAs used in this study 
	
Target gene Species siRNA (Cat. No.) 
- - Negative control (SI03650325) 
Perk 








































Quantitative real-time PCR 
We isolated mRNA using either Trizol reagent (Invitrogen) or Quick RNA 
MiniPrep kits (Zymo Research), and synthesized cDNA using 700 ng- 2 µg of total RNA 
as a template, a T18 primer, and MMLV reverse transcriptase (NEB). We measured 
relative mRNA abundance by qPCR using the Mastercycler ep realplex (Eppendorf) with 
SYBR green fluorescent dye. We measured each sample in triplicate and normalized 
target mRNA levels to those of ribosomal protein (Rpl19) mRNA. The primers used for 
qPCR are shown in Table 4.2.  
 
Western blot  
We washed Hek293 cells in PBS before lysing in RIPA buffer (25 mM Tris, pH 
7.6, 150 mM NaCl, 1% NP-40, 1% Na-deoxycholate, and 0.1% SDS) with protease 
inhibitors (Thermo Scientific) and phosphatase inhibitors (50 mM NaF and 0.2 mM Na-
orthovanadate complexes). Protein concentration was determined using Pierce BCA 
protein assay kit (Thermo Scientific). We added 4x SDS loading buffer and DTT to each 
sample. Samples were boiled for 5 min and resolved by 4-12% NuPAGE Bis-Tris gels 
(Invitrogen). We transferred them to nitrocellulose membranes and probed for primary 
antibodies followed by a secondary IRDye 800CW antibody (Licor 926-32210, 1:10000). 
We scanned the blots and quantified band intensities using a Licor Odyssey imager. Each 
experiment was performed at least three times. Primary antibodies used for western blots 
were as follows: anti-Hes1 (santa cruz 25392, 1:200), anti-histone H3 (abcam 1791, 
1:10000), anti-Ser51-P eIF2α (abcam 32157, 1:1000), anti-total eIF2α (abcam 26197, 
1:250), and anti-Gadd34 (santa cruz 8327, 1:400).  
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Table 4.2. Primers used for qPCR 
 
Name Sequences (5´- 3´) 
dRpl19 Forward: AGGTCGGACTGCTTAGTGACC Reverse: CGCAAGCTTATCAAGGATGG 
mRpl19 Forward: CTGATCAAGGATGGGCTGAT Reverse: GCCGCTATGTACAGACACGA 
hRpl19 Forward: ATGTATCACAGCCTGTACCTG Reverse: TTCTTGGTCTCTTCCTCCTTG 
hairy Forward: CGTGCCCGTATTAACAACTG Reverse: TCTTAACGCCATTGATGCAG 
mHes1 Forward: TAACGCAGTGTCACCTTCCA Reverse: AGGCGCAATCCAATATGAAC 
hHes1 Forward: CTGTCATCCCCGTCTACACC Reverse: AGGCGCAATCCAATATGAAC 
mPerk Forward: TGGACTGGTGACTGCTATGG Reverse: GGTGCTGAATGGGTAGAGGA 
hPerk Forward: CAGGCTTTTCCATCCTCATC Reverse: AACAACTCCAAAGCCACCAC 
mGadd45b Forward: GCTGTGGAGTGTGACTGCAT Reverse: ACGACTGGATCAGGGTGAAG 
hGadd45b Forward: GCCAGCTACTGCGAAGAAAG Reverse: CTCACTCCCCTTCTCCTCCT 
mBim Forward: CGACAGTCTCAGGAGGAACC Reverse: CCTTCTCCATACCAGACGGA 
mDr5 Forward: AGTAGTGCTGCTGATTGGAG Reverse: CCTGTTTTCTGAGTCTTGCC 
mPuma Forward: GCCCAGCAGCACTTAGAGTC Reverse: TGTCGATGCTGCTCTTCTTG 
mTrb3 Forward: GGAACCTTCAGAGCGACTTG Reverse: CCCAAAAAGTCAGGAGAAAGC 
mGadd34 Forward: CTGCAAGGGGCTGATAAGAG Reverse: AGGGGTCAGCCTTGTTTTCT 
hGadd34 Forward: GAGGAGGCTGAAGACAGTGG Reverse: AATTGACTTCCCTGCCCTCT 
mChop Forward: TATCTCATCCCCAGGAAACG Reverse: CTGCTCCTTCTCCTTCATGC 




Cell viability assay 
After 4 h DTT or 7 h Tg treatment, we first removed floating dead MC3T3-E1 
cells by aspirating media. We then trypsinized cells and counted the live cells using a 
hemocytometer. For Hek293 cells, we collected all cells after 4 h DTT treatment, then 
spun them down at 1000 g for 5 min to separate the dead from live cells. We resuspended 
cell pellets in media and counted live cells on the hemocytometer.  
 
Results 
Hairy/Hes1 mRNA is up-regulated during ER stress 
Genome-wide expression analyses have previously reported that Drosophila hairy 
and mouse Hes1 mRNA levels increase during ER stress. To confirm and extend these 
findings, we treated Drosophila S2, MC3T3-E1, and Hek293 cells with either 
dithiothreitol (DTT), a reducing agent that disrupts disulfide bond formation, or 
thapsigargin (Tg), which depletes ER calcium reserves. We then measured relative 
mRNA levels of Drosophila hairy, or mammalian Hes1 by quantitative real-time PCR 
(qPCR). We found that hairy/Hes1 mRNA levels increase during ER stress in various 
cells (Figure 4.1, A and B).  
Since the increase in the steady-state levels of Hes1 mRNA could result from 
regulation of either transcription or mRNA degradation, we next investigated whether ER 
stress affects the stability of Hes1 mRNA. We treated both MC3T3-E1 and Hek293 cells 
with the transcription inhibitor actinomycin D, and monitored relative Hes1 mRNA levels 
over time in the presence and absence of DTT. Hes1 mRNA was rapidly degraded in both 




Figure 4.1. Hes1 mRNA is increased by ER stress in various cells. We treated (A) 
Drosophila S2 cells with 2 mM DTT for 2.5 h, and (B) MC3T3-E1 and Hek293 cells 
with either DTT (2 mM for 5 h) or Tg (2 µM for 2 h) to induce ER stress. We then 
measured relative hairy/Hes1 mRNA levels by qPCR. Data are represented as means ± 
SDs of at least three independent experiments. C) We treated cells with 2 µg/mL 
actinomycin D in the presence or absence of DTT. The means and SDs for at least two 
independent experiments are shown. Time course of (D) Hes1 mRNA and (E) protein in 
Hek293 cells exposed to DTT for indicated times. Shown are representative western blot 
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 (Figure 4.1C). The magnitude of this stabilization fully accounted for the increase in 
Hes1 mRNA abundance during ER stress.  
Unlike the Hes1 mRNA, Hes1 protein levels did not increase during ER stress in 
Hek293 cells, as determined by western blotting (Figure 4.1, D and E). Hes1p levels 
initially declined with DTT, returning to normal levels by 4 h. As Hes1 is reported to be a 
highly unstable protein, the initial decrease may be a result of UPR-mediated 
translational attenuation. Subsequent recovery of Hes1p levels is likely to be facilitated 
by the increase in mRNA levels, as eIF2α remains phosphorylated at 4 h in these 
conditions. 
 
Hes1 mRNA stabilization is dependent on Perk-mediated  
translational attenuation 
To determine which branch of the UPR signaling network is responsible for the 
up-regulation of Hes1 during ER stress, we depleted each UPR transducer from 
Drosophila S2 cells using RNAi, then compared the mRNA levels of hairy in cells 
treated with and without DTT for 2.5 h (the time of maximal hairy induction in these 
cells). Perk was the sole UPR component whose depletion resulted in a loss of hairy up-
regulation (Figure 4.2A).  
To test whether mammalian Perk is necessary for Hes1 mRNA up-regulation, we 
transfected both MC3T3-E1 and Hek293 cells with siRNAs targeting either Perk or a 
negative control sequence, and induced ER stress with DTT. Induction of Hes1 was 
significantly blocked by Perk knockdown (Figure 4.2, B and C), indicating a conserved 






Figure 4.2. Translation attenuation mediated by Perk is important for Hes1 regulation. 
(A) We incubated S2 cells with dsRNA targeting either GFP or known UPR transducers 
and incubated with and without DTT for 2.5 h. Control indicated untransfected cells. ** p 
< 0.005 vs. DTT-treated GFP knockdown cells, two-tailed unpaired t-test. The means and 
SDs for at least two independent experiments are shown. We transfected MC3T3-E1 and 
Hek293 cells with either Neg (negative control) or Perk siRNAs and then incubated them 
with or without DTT for 4 h. mRNA levels of (B) Hes1 and (C) Perk were measured by 
qPCR. (D) We added 200 nM ISRIB, ER stressor (2 mM DTT or 2 µM Tg), or both for 2 
h (4 h DTT for MC3T3-E1) to cells, and measured Hes1 mRNA levels. Shown are means 














































































































































































Perk phosphorylates eIF2α, thereby attenuating translation initiation, as well as 
phosphorylating other targets such as Nrf2,20 diacylglycerol,21 and FOXO1.22 To 
determine which aspect of Perk is important for Hes1 mRNA regulation, we used 
integrated stress response inhibitor (ISRIB), a small molecule that blocks translational 
attenuation upon ER stress by inhibiting the downstream effects of eIF2α 
phosphorylation.23 ISRIB greatly reduced Hes1 mRNA levels induced by either DTT or 
Tg treatment in both MC3T3-E1 and Hek293 cells (Figure 4.2D). Overall, these results 
indicate that Perk-mediated translational attenuation is important for the up-regulation of 
Hes1 during ER stress.  
 
Translational attenuation is sufficient to stabilize the Hes1 mRNA 
To determine whether translational attenuation is sufficient to stabilize the Hes1 
mRNA, we used two alternative approaches to attenuate translation in Hek293 cells. 
First, we treated cells with the translation elongation inhibitor cycloheximide (CHX). 
CHX treatment resulted in both an increase in the steady-state Hes1 mRNA abundance, 
as well as a stabilization of the Hes1 mRNA, measured by decreased degradation 
following actinomycin D treatment (Figure 4.3, A and B). Second, we treated cells with 
arsenite, which activates the oxidative stress-responsive eIF2α kinase heme-regulated 
inhibitor (HRI), resulting in translation attenuation. Like ER stress and CHX, arsenite 
treatment led to the stabilization of the Hes1 mRNA (Figure 4.3A), indicating that 
translation inhibition is sufficient for this effect.  
Interestingly, arsenite alone did not increase steady-state Hes1 mRNA levels, 




Figure 4.3. Translation inhibition is sufficient to stabilize the Hes1 mRNA. (A) We 
treated Hek293 cells with 2 µg/mL actinomycin D in the presence or absence of either 
100 µM Arsenite or 35 µM cycloheximide (CHX). Relative Hes1 mRNA abundance was 
determined using qPCR. (B) Hes1 mRNA levels in Hek293 cells either treated with CHX 
or Arsenite for 4 h. (C) Representative western blot and quantification of timecourse 
experiments on Hek293 cells treated with Arsenite. Hes1 and phosphorylated eIF2α 
(Ser51) levels were measured in whole lysates and normalized to histone H3 and total 
eIF2α, respectively. (D) We transfected 3T3 and Hek293 cells with either Neg or Upf1 
siRNAs and then incubated them with or without actinomycin D for indicated times. We 
measured mRNA abundance of Hes1 and Gadd45b as a control NMD target. For all 
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during ER stress (Figure 4.3, B and C). This suggests there are compensatory 
mechanisms to maintain low levels of Hes1 mRNA during oxidative stress. Furthermore, 
Hes1 protein levels continued to decline over time with arsenite, rather than recover as 
we observed during ER stress (Figure 4.3C). This could be explained by either the lack of 
Hes1 mRNA up-regulation, or by the stronger phosphorylation of eIF2α seen with 
arsenite compared to DTT treatment.  
The fact that translation attenuation is both necessary and sufficient for 
stabilization of the Hes1 mRNA suggests that this mRNA is a target of a translation-
dependent mRNA decay pathway. A likely candidate for such a pathway is nonsense-
mediated decay (NMD), which is known to be inhibited during ER stress.24 However, 
depleting either Hek293 or mouse 3T3 cells of the core NMD factor Upf1 by RNAi did 
not affect the stability or steady-state levels of Hes1 mRNA, despite having the expected 
effects on the known NMD target Gadd45b (Figure 4.3D). Thus, while Hes1 mRNA is 
stabilized when translation is inhibited, it does not appear to be a direct target of NMD.   
 
Depletion of Hes1 induces cell death in Gadd34-dependent manner  
in mammalian cells undergoing ER stress 
To characterize the role of Hes1 during ER stress, we examined the viability of 
MC3T3-E1 cells transfected with either Neg or Hes1 siRNAs. Of note, Hes1 knockdown 
by itself did not affect cell viability in the absence of ER stressors (Figure 4.4, A and B). 
In contrast, DTT or Tg treatment significantly compromised cell viability in a dose-













Figure 4.4. Knockdown of Hes1 reduces cell viability in a Gadd34-dependent manner in 
response to ER stress. We performed cell viability assay on control or Hes1-depleted 
MC3T3-E1 cells in the presence of different concentrations of (A) DTT (4 h) or (B) Tg (7 
h). (C) We compared the RNA levels of apoptotic genes induced by ER stress and Hes1 
in control and Hes1-depleted MC3T3-E1 cells. (D) Effect of double knockdown 
Hes1/Gadd34 on viability of MC3T3-E1 cells upon DTT treatment was determined. Hes1 
and Gadd34 knockdown was confirmed by qPCR. (E) We did cell viability assay on 
Hek293 cells transfected either Neg or Hes1 siRNAs in the presence of DTT (4 h). (F) 
Samples from (E) were analyzed for relative mRNA levels of Gadd34, Chop, and Hes1. 
(G) Representative western blot and quantification of DTT timecourse experiments on 
control and Hes1-deficient Hek293 cells. Gadd34 levels were measured in whole lysates 
and normalized to histone H3. (H) We measured viability of Hek293 cells double 
knocked down Hes1/Gadd34 in the presence of DTT, and relative mRNA levels of Hes1 
and Gadd34 by qPCR. (I) Samples from (G) were analyzed for phosphorylated eIF2α 





















Severe ER stress triggers cell death through expression of various pro-apoptotic 
genes.10 We therefore measured the mRNA levels of these genes in the presence and 
absence of ER stress, in control and Hes1-depleted MC3T3-E1 cells. Gadd34 was the 
only mRNA we tested whose expression was affected by Hes1 knockdown (Fig 4.4C). 
Expression of Gadd34 was further increased during ER stress in cells lacking Hes1, 
consistent with a role for Hes1 in repressing the transcription of Gadd34.  
To test whether the knockdown of Hes1 results in cell death by increasing 
Gadd34, we compared ER stress sensitivity in cells depleted of Hes1, Gadd34, and both. 
Co-depletion of Hes1 and Gadd34 nearly completely rescued the cell death defects 
caused by depletion of Hes1 alone (Figure 4.4D). Together, these data showed that the 
cell death-inducing downstream target of Hes1 during ER stress is Gadd34.  
We confirmed these findings in Hek293 cells; depletion of Hes1 reduced cell 
viability upon 4h DTT treatment (Figure 4.4E), which was completely rescued by the 
double knockdown of Hes1 and Gadd34 (Figure 4.4H). Also, Hes1-depleted cells showed 
elevated levels of Gadd34 mRNA (Figure 4.4F) and protein (Figure 4.4G).  
Having established that Hes1 regulates cell survival in Gadd34-dependent manner 
in response to ER stress, we next asked how Gadd34 induces cell death. It has been 
reported that Gadd34 promotes cell death by dephosphorylating eIF2α, leading to the 
recovery of protein synthesis and potentially exacerbating ER stress. However, we did 
not observe reduced phospho-eIF2α in Hes1-deficient cells as compared to control cells 





In response to ER stress, the UPR mediates both adaptive and apoptotic pathways, 
depending on the duration and intensity of the stress. Many apoptotic genes involved in 
ER stress-induced cell death have been identified; however, the mechanism underlying 
the molecular switch from pro-survival phase to cell death is still largely unknown. We 
found that ER stress stabilizes Hes1 mRNA (Figure 4.1D), whose important function 
during development is known to determine cell fates. During ER stress, Hes1 functions as 
a negative regulator of cell death, potentially by repressing the pro-apoptotic Gadd34.  
Our data indicate that Perk, by attenuating translation during ER stress, stabilizes 
the Hes1 mRNA (Figure 4.2, B and D), an effect that is mimicked by CHX- and arsenite-
mediated translation inhibition (Figure 4.3 A and B). The mechanism by which reduced 
translation affects Hes1 mRNA stability requires further investigation, although the lack 
of effect of Upf1 depletion suggests that Hes1 is not a target of NMD (Figure 4.3D). 
Hes1 is regulated by microRNAs such as miR-23 and miR-9 during neuronal 
differentiation,25,26 and it is possible that miRNAs regulate Hes1 during ER stress as well. 
Consistent with this idea, the Perk branch of the UPR has been linked to miRNAs 
favoring cell survival.27 For example, Perk-dependent expression of miR-211 suppresses 
Chop expression at early phases of ER stress.28 
We found that Hes1 protects cells from ER stress-induced cell death, possibly 
through transcriptional repression of the pro-apoptosis gene Gadd34 (Figure 4). 
Expression of Gadd34 is induced by Atf4 and Chop, which are also downstream targets 
of Perk during ER stress. Because Atf4-Chop and Hes1 are each regulated by Perk but 
have opposite effects on Gadd34 expression, the balance and timing of these branches of 
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the UPR are likely important in deciding whether cells live or die during ER stress.  
Although the role of ER stress in cancer is complicated, many components of the 
UPR have been implicated in cancer development.29 Intriguingly, a growing number of 
studies has reported that cancer cells show elevated levels of Hes1 as compared to non-
malignant cells.30,31 Moreover, high expression of Hes1 mRNA is associated with poor 
prognosis in colorectal cancer.32,33 Therefore, it will be interesting to see whether tumors 
with increased levels of Hes1 are more resistant to apoptosis than tumors with low levels 
of Hes1. Our findings that Perk enhances Hes1 mRNA stability, which prevents apoptosis 
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The UPR is a complex signal transduction pathway that has diverse effects to 
recover ER function beyond its ability to maintain protein homeostasis during ER stress. 
In addition to its direct impacts on the protein secretory pathway, increasing numbers of 
studies are investigating the influence of the UPR on other cellular processes including 
inflammation, lipid synthesis, and apoptosis. In this dissertation, I have discussed two 
such processes, carbon metabolism and apoptosis. Here I summarize my main findings 
and discuss further their implications and possible future directions. 
 
Does ATF4 Cooperatively Work to Regulate Glycolytic Genes  
in ER Stress and Development? 
We found that ER stress induces a coordinated change in the expression of genes 
involved in central carbon metabolism that is highly reminiscent of the Warburg effect 
(Chapter 2). Genes encoding enzymes that carry out glycolysis and lactate conversion 
from pyruvate were upregulated while genes encoding proteins in the TCA cycle and 
respiratory chain complexes were downregulated in Drosophila S2 cells treated with ER 
stressors. We identified a second transcription factor, ATF4, involved in regulation of 
glycolytic genes and lactate dehydrogenase (Ldh) in flies during ER stress. It has been 
reported that the Drosophila melanogaster estrogen-related receptor (dERR), which was 
the only transcription factor known to regulate glycolytic genes in flies, directs a 
metabolic switch that supports larval growth.1 ATF4 is also known to be important in 
regulation of developmental timing and metamorphosis2 and null mutants for Atf4 are 
lethal.3 Consistent with these findings, we found that ATF4 depletion at early stages of 
fly development was lethal. Therefore, it is possible that metabolic reprogramming in 
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Drosophila mid-embryogenesis is accomplished by ATF4 branch of the UPR as in ER 
stress. 
Moreover, we found that ATF4 is sufficient to induce a subset of glycolytic 
genes, as overexpression of ATF4 led to increased expression of phosphofructokinase 
(Pfk) and Ldh but not triosephosphate isomerase (Tpi). This result raises the possibility of 
collaborative role of ATF4 in glycolytic gene regulation with another transcription factor. 
In fact, Tpi, whose expression was not increased by ATF4 overexpression, has putative 
binding sites for dERR as well as ATF4 within the promoter,4 supporting the idea that 
ATF4 may regulate transcription of some glycolytic genes with dERR under ER stress.  
 
How is the TCA Cycle Controlled by the UPR? 
Unlike regulation of glycolytic genes and Ldh, down-regulation of the TCA cycle 
and respiratory chain complex genes is conserved in mammalian cells during ER stress 
(data not shown). However, the mechanism behind down-regulation of these genes 
remains unclear, in part because the known transcription factors that mediate the UPR do 
not appear to affect regulation of these genes. Previous work in D. melanogaster adapted 
to hypoxia shows that hairy (D. melanogaster homologue of Hes1) represses several 
TCA cycle genes under hypoxia.5 Also, the hairy loss-of-function mutants losing 
suppression of TCA cycle genes showed reduced survival rate under hypoxia, 
highlighting the importance of metabolic regulation by hairy to survival during hypoxia. 
Interestingly, we found that expression of hairy is increased in response to ER stress 
(Chapter 4). Taken together, down-regulation of TCA cycle genes may be mediated by 
transcriptional repressor hairy during ER stress. While technical problems prevented us 
	 74	
from testing this directly, our preliminary data obtained in mouse cells indicated that 
depletion of Hes1 (mammalian homologue) affects down-regulation of one TCA cycle 
gene, isocitrate dehydrogenase 3 (Idh3a), in response to ER stress. 
Alternatively, reduced expression of some TCA cycle genes can be achieved 
through reducing mRNA stability rather than transcriptional control. We previously 
found that when we inhibited transcription with actinomycin D (Act D) in the absence 
and the presence of ER stressor DTT in S2 cells, the relative transcript levels of TCA 
cycle enzymes were stable in Act D treated cells, but significantly decreased in both Act 
D and DTT treated cells (data not shown). This raises a possibility that the reduced level 
of TCA cycle genes results not from a downregulation of their transcription, but from an 
increase in their decay rates. Consistent with this hypothesis, our preliminary results 
using an assay based on a reporter plasmid showed that CG7430, a gene encoding one of 
the TCA cycle enzymes in α-ketoglutarate dehydrogenase complex, is degraded under 
ER stress. This reporter plasmid expresses the coding sequence and 3’ untranslated 
region (UTR) of CG7430 under the control of the copper-inducible Drosophila 
metallothionein promoter (not conditioned to endogenous factors), and thus removal of 
copper from the media allows for measurement of mRNA degradation. By using this 
reporter assay for other TCA cycle and respiratory chain complex genes, we will confirm 
whether the increase in mRNA decay is a common mechanism of regulation for these 
genes. Furthermore, it is of interest whether TCA cycle and respiratory chain complex 
genes are degraded locally on the cytoplasmic surface of the mitochondria, since it has 
been reported that numerous mRNA encoding mitochondrial proteins are closely 
associated with mitochondria.6,7 Since we knew that mitochondrial-to-nuclear DNA ratio, 
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an indicator of mitochondrial mass, was not changed under ER stress (data not shown), 
this rules out the possibility that global downregulation of TCA cycle and respiratory 
chain complex genes under ER stress is due to degradation of mitochondria, a process 
called mitophagy.  
   
How Do Cells Balance Between Adaptive and Apoptotic Responses  
to ER Stress? 
One important function of the UPR pathway is to induce apoptotic cell death if 
ER stress is severe or prolonged. Although many proteins have been identified in the 
process of ER stress-induced apoptosis, the precise mechanism by which cells switch to 
the apoptotic pathway from an adaptive pathway in response to irreversible ER stress is 
still not clear. We found a novel mechanism regulating apoptosis during ER stress; ATF4 
and Hes1 regulated by PERK have opposite effects on the regulation of the apoptotic 
gene Gadd34 to determine whether cells die or not (Chapter 4). While there has been 
evidence that expression of GADD34 correlates with apoptosis induced by ER stress8 and 
ATF4 is required for transcription of Gadd34,9 this work was the first to demonstrate that 
expression of Gadd34 is negatively regulated by the transcription repressor Hes1. 
Although the detailed mechanism underlying regulation of Hes1 by ER stress remains to 
be further investigated, we showed that translation attenuation mediated by PERK is 
important for Hes1 mRNA stabilization.  
Based on these results, we hypothesize that Gadd34 levels, which are controlled 
by ATF4 and Hes1 through PERK, are key to determining overall cell fate. Similar to the 
contribution of GADD34 on ER stress-induced apoptosis, death receptor 5 (DR5) has 
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been also known to act as a gauge for persistence of ER stress by integrating opposing 
UPR signals; the PERK branch induces Dr5 transcription, whereas IRE1 degrades Dr5 
mRNA.10 Elevated DR5 results in caspase 8-mediated apoptosis in response to ER stress, 
but Dr5 mRNA was not increased during ER stress in our experimental conditions. 
Therefore, it will be interesting to monitor ER stress-induced apoptosis and the relative 
kinetics of regulation of Gadd34 and Dr5 to study how these pathways function to 
commit the cell to death.  
 
How Does GADD34 Induce Apoptosis During ER Stress? 
While there have been reports that GADD34 leads to apoptosis via premature 
dephosphorylation of eIF2α, which in turn leads to increased protein synthesis 
exacerbating ER stress,11-14 it is still not completely understood how GADD34 mediates 
apoptosis. We showed that cells depleted of Hes1 increased GADD34 and apoptotic cell 
death in response to ER stress, but they did not show reduced levels of eIF2α 
phosphorylation. In fact, GADD34 have a number of interacting proteins and 
dephosphorylate them under various types of cellular stress.15-17 We are currently 
investigating whether phosphorylation levels of any potential target proteins would be 
affected by Hes1 knockdown during ER stress. Another possibility is that GADD34 
regulates cell viability through regulation of transcription of p21, a cyclin-dependent 
kinase inhibitor. Although it is not known whether GADD34 acts as part of a 
transcription factor complex, it interacts with zinc-finger transcription factor, which is 
known to bind to p21 promoter.18 Also, recent study showed that the GADD34 mutant, 
which lacks the binding domain for protein phosphatase 1, had a reduced ability to inhibit 
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cell viability and enhance p21 expression as compared to the wild-type GADD34.19  
 
Cytoprotective Functions of PERK May Contribute to  
Cancer Progression 
The work described here is important not just for our understanding of basic UPR 
biology, but also for our ability to understand and treat diseases such as cancer. During 
tumorigenesis, the high proliferation rate of cancer cells requires increased activities of 
the ER to satisfy their demands for increased synthesis of proteins and lipids. Various 
cancer types showed evidence of ER stress and UPR activation20; thus the UPR, 
especially PERK branch, has received considerable attention as a promising target of 
anti-cancer therapies.21 There is evidence that PERK promotes cancer development as it 
enhances angiogenesis22 and autophagy23 and limits oxidative DNA damage.24 However, 
considering that PERK induces both adaptive and apoptotic responses depending on the 
intensity and duration of the stress, it is no surprise that PERK could serve as 
cytoprotective or cytotoxic function in cancer, making the contribution of PERK in 
cancer development complicated.25 In this regard, a better understanding of the novel 
physiological impacts of the PERK and what dictates PERK pro-apoptotic signaling from 
pro-survival signaling has been required to develop cancer therapeutics that target PERK 
activity. We predict that PERK promotes the ability of cancer cells to adapt to and 
survive the hostile microenvironment through activation of the metabolic shift toward 
glycolysis by ATF4 and prevention of apoptosis by Hes1 (Figure 5.1). Aerobic glycolysis 
has been considered to be fundamental to the transformation of normal cells to cancer 








Figure 5.1 Model of the cancer-supporting function of PERK. ATF4 and Hes1 which are 
activated by the PERK branch of the UPR might contribute to acquisition of cancer 
























producing anticancer effects.26 As noted above, expression of both Pfk and Ldh was 
increased in our ATF4 overexpression experiment. Therefore, our studies of ATF4 in 
regulation of aerobic glycolysis will help in understanding tumor metabolism that 
facilitates cancer cell proliferation. Furthermore, consistent with our finding that Hes1 
determines overall cell fate in response to ER stress by acting as a negative regulator of 
apoptosis, Hes1 has been reported to play an important role in tumorigenesis.27 In 
addition to high levels of glycolysis, evasion of apoptosis has evolved to become 
hallmarks of cancer.28 In the future, it will be interesting to see if cancer cells showing 
high levels of Hes1 will have less expression of Gadd34 and are resistant to apoptosis.  
Over the past two decades, the contribution of ER stress to various diseases 
including cancer, diabetes, and neurodegenerative diseases has been reported. Although 
the exact direction of the cause and effect relationship between these diseases and ER 
stress still remains elusive, targeting the UPR has emerged as a promising therapeutic 
strategy against these diseases. However, further studies are needed to expand our 
understanding of the UPR signaling pathway itself and its physiological functions to treat 
diseases driven by ER stress. In this work, I have discovered novel outputs of the UPR 
beyond the homeostatic control of protein folding and processing which have been the 
main focus of the UPR. Through these insights and our continued work, we are 
connecting the UPR to other cellular pathways such as glucose metabolism that does not 
appear to be directly linked to cellular protein quality control but is important for the 
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